The Cancer Institute Administrative Office (AO) plays a crucial role in providing resources and efficient and effective administrative expertise to support the complex and expanding cancer basic and clinical research enterprise across the NYU Langone Medical Center. This includes administrative support to the Office of the Director, Associate Directors, Shared Resource Directors, Program Leaders, and NYUCI membership, as well as the investigators at the Cancer Research Center and the faculty in the Division of Hematology and Medical Oncology. The overarching goal for administration is to facilitate research and provide the infrastructure to move discoveries into the clinical setting. This is done through strategic planning and evaluation initiatives, business and financial planning for research programs and shared resources, development of policies and procedures for prudent financial and grants management for investigators at the Cancer Research Center and Division of Hematology and Medical Oncology, staffing of program meetings, scientific retreats, and seminars, supporting the submission of administratively demanding complex grants such as SPORE's and training grants, human resources, budget and finance, space, informatics, and facilities planning. The administrative team is responsible for all interactions across the NYU Langone Medical Center corporate offices (Grants Finance, Finance, IRB, Office of Clinical Trials, Office of Collaborative Sciences, Sponsored Programs Administration, Medical Center IT, and the Office of Communications). The AO provides services beyond the activities related to the CCSG such as fiscal management of clinical activities, auditing and oversight of clinical research billing compliance, the integration of clinical research operations throughout all clinical sites at the Cancer Institute, and academic and administrative oversight of the Division of Hematology and Medical Oncology and the Cancer Research Laboratories. The core mission of the CCSG defines and dictates the structure and decision-making processes within the administrative unit. There are eight major areas of focus for research administration: central CCSG administration, grants management, membership, shared resources, structure for inter- and intra-disciplinary collaborations, research program support, informatics, and financial management of the Cancer Institute. Support is requested for only those activities directly related to the CCSG.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
New York
United States
Zip Code
Nancy, Patrice; Siewiera, Johan; Rizzuto, Gabrielle et al. (2018) H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. J Clin Invest 128:233-247
Wang, Shiyang; Liechty, Benjamin; Patel, Seema et al. (2018) Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors. J Neurooncol 138:183-190
Ge, Wenzhen; Clendenen, Tess V; Afanasyeva, Yelena et al. (2018) Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer 142:2215-2226
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:
Ruggles, Kelly V; Wang, Jincheng; Volkova, Angelina et al. (2018) Changes in the Gut Microbiota of Urban Subjects during an Immersion in the Traditional Diet and Lifestyle of a Rainforest Village. mSphere 3:
Marié, Isabelle J; Chang, Hao-Ming; Levy, David E (2018) HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies. J Exp Med 215:3194-3212
Gupta, Ankit; Xu, Jing; Lee, Shirley et al. (2018) Facile target validation in an animal model with intracellularly expressed monobodies. Nat Chem Biol 14:895-900
Lee, Hyun-Wook; Park, Sung-Hyun; Weng, Mao-Wen et al. (2018) E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci U S A 115:E1560-E1569
Evensen, Nikki A; Madhusoodhan, P Pallavi; Meyer, Julia et al. (2018) MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. Haematologica 103:830-839

Showing the most recent 10 out of 1170 publications